Abstract
Rolf Antonie Loch, Alex Perálvarez-Marín, Henrietta Nielsen, Angeliki Chroni, Jinghui Luo
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
No local reference links have been materialized yet.
No local citing links have been materialized yet.
10.1146/annurev-biochem-061516-045115
10.1146/annurev-biochem-061516-045115
10.1111/joim.12506
10.1111/joim.12506
10.1016/j.bpc.2021.106699
10.1016/j.bpc.2021.106699
Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee
10.1080/13506129.2020.1835263 · 2020
Single-molecule studies of amyloid proteins: from biophysical properties to diagnostic perspectives
10.1017/s0033583520000086 · 2020
10.1002/anie.202104497
10.1002/anie.202104497
Structural symmetry and protein function
10.1146/annurev.biophys.29.1.105 · 2000
10.1042/bst20190283
10.1042/bst20190283
10.1038/aps.2017.28
10.1038/aps.2017.28
10.1113/jphysiol.2006.111203
10.1113/jphysiol.2006.111203
10.1016/j.bpc.2020.106505
10.1016/j.bpc.2020.106505
Confidence 92%
datacite
Confidence 0%
10.1016/j.bpc.2020.106507
10.1016/j.bpc.2020.106507
10.1021/acs.chemrev.0c01122
10.1021/acs.chemrev.0c01122
10.1074/jbc.r116.714576
10.1074/jbc.r116.714576
Lecanemab in early Alzheimer’s disease
10.1056/nejmoa2212948 · 2023
10.1038/s41591-019-0675-0
10.1038/s41591-019-0675-0
10.1074/jbc.r800009200
10.1074/jbc.r800009200
10.1146/annurev.genom.1.1.507
10.1146/annurev.genom.1.1.507
APOE alleles and extreme human longevity
10.1093/gerona/gly174 · 2019
10.1016/j.nbd.2022.105631
10.1016/j.nbd.2022.105631
APOE4 is associated with cognitive and pathological heterogeneity in patients with Alzheimer’s disease: a systematic review
2020
APOE alleles and diet in brain aging and Alzheimer’s disease
10.3389/fnagi.2020.00150 · 2020
10.1073/pnas.1705080114
10.1073/pnas.1705080114
10.1073/pnas.1106420108
10.1073/pnas.1106420108
APOE genotype regulates pathology and disease progression in synucleinopathy
10.1126/scitranslmed.aay3069 · 2020
10.1016/s0140-6736(94)90691-2
10.1016/s0140-6736(94)90691-2
Dissecting the association of apolipoprotein E gene polymorphisms with type 2 diabetes mellitus and coronary artery disease
2022
The role of apoE4 in disrupting the homeostatic functions of astrocytes and microglia in aging and Alzheimer’s disease
2019
10.1007/s00109-018-1632-y
10.1007/s00109-018-1632-y
10.1038/nature11087
10.1038/nature11087
10.1194/jlr.r800069-jlr200
10.1194/jlr.r800069-jlr200
10.1016/s0021-9258(18)34954-8
10.1016/s0021-9258(18)34954-8
10.3233/jad-190175
10.3233/jad-190175
10.1073/pnas.151254698
10.1073/pnas.151254698
APOE-amyloid interaction: therapeutic targets
2020
The amyloid hypothesis of Alzheimer’s disease at 25 years
10.15252/emmm.201606210 · 2016
10.1194/jlr.r075481
10.1194/jlr.r075481
10.1007/s007020200068
10.1007/s007020200068
10.1038/nrm2101
10.1038/nrm2101
Amyloid structure exhibits polymorphism on multiple length scales in human brain tissue
2016
10.1096/fj.201900071r
10.1096/fj.201900071r · doi-reference
10.17226/23657
10.17226/23657 · doi-reference
10.1016/s0140-6736(06)69113-7
10.1016/s0140-6736(06)69113-7 · doi-reference
10.1093/brain/awy165
10.1093/brain/awy165 · doi-reference
Alzheimer’s disease genetic risk factor APOE-ε4 also affects normal brain function
10.2174/1567205013666160401115127 · doi-reference
10.1016/j.neuron.2017.11.014
10.1016/j.neuron.2017.11.014 · doi-reference
10.1089/humc.2017.231
10.1089/humc.2017.231 · doi-reference
10.1038/s41591-018-0004-z
10.1038/s41591-018-0004-z · doi-reference
10.1021/jm3008618
10.1021/jm3008618 · doi-reference
Cross-talk of membrane lipids and Alzheimer-related proteins
10.1186/1750-1326-8-34 · doi-reference
Amyloidogenic intrinsically disordered proteins: new insights into their self-assembly and their interaction with membranes
10.3390/life10080144 · doi-reference
10.1007/s00249-020-01424-1
10.1007/s00249-020-01424-1 · doi-reference
Amyloid beta-protein interactions with membranes and cholesterol: causes or casualties of Alzheimer’s disease
10.1016/s0005-2736(03)00025-7 · doi-reference
10.15252/embr.201540614
10.15252/embr.201540614 · doi-reference
10.1111/jnc.12637
10.1111/jnc.12637 · doi-reference
10.1523/jneurosci.5543-03.2004
10.1523/jneurosci.5543-03.2004 · doi-reference
10.1042/bj20040777
10.1042/bj20040777 · doi-reference
10.1016/j.ajpath.2011.05.047
10.1016/j.ajpath.2011.05.047 · doi-reference
10.1016/j.cmet.2017.08.024
10.1016/j.cmet.2017.08.024 · doi-reference
10.1016/j.cell.2014.12.019
10.1016/j.cell.2014.12.019 · doi-reference
10.1016/j.plipres.2010.09.001
10.1016/j.plipres.2010.09.001 · doi-reference
Direct binding of cholesterol to the amyloid precursor protein: an important interaction in lipid-Alzheimer’s disease relationships?
10.1016/j.bbalip.2010.03.008 · doi-reference
Prion infection impairs cholesterol metabolism in neuronal cells
10.1074/jbc.m113.535807 · doi-reference
High cholesterol diet induces tau hyperphosphorylation in apolipoprotein e deficient mice
10.1016/j.febslet.2005.10.024 · doi-reference
10.1097/nen.0000000000000103
10.1097/nen.0000000000000103 · doi-reference
Motions and interactions of phospholipid head groups at the membrane surface. 3. Dynamic properties of amine-containing head groups
10.1021/bi00528a014 · doi-reference
10.1146/annurev.biophys.32.110601.141803
10.1146/annurev.biophys.32.110601.141803 · doi-reference
10.1016/j.bpc.2021.106718
10.1016/j.bpc.2021.106718 · doi-reference
Cholesterol depletion reduces aggregation of amyloid-beta peptide in hippocampal neurons
10.1016/j.nbd.2006.04.015 · doi-reference
10.1016/j.str.2016.07.007
10.1016/j.str.2016.07.007 · doi-reference
Tau protein liquid–liquid phase separation can initiate tau aggregation
10.15252/embj.201798049 · doi-reference
Phase separation of RNA-binding proteins in physiology and disease: an introduction to the JBC reviews thematic series
10.1074/jbc.rev119.007944 · doi-reference
Apolipoprotein E4 forms a molten globule: a potential basis for its association with disease
10.1074/jbc.m204898200 · doi-reference
10.1016/j.bbapap.2020.140535
10.1016/j.bbapap.2020.140535 · doi-reference
ApoE4-specific misfolded intermediate identified by molecular dynamics simulations
10.1371/journal.pcbi.1004359 · doi-reference
Apolipoprotein E inhibits the depolymerization of β2-microglobulin-related amyloid fibrils at a neutral pH
10.1021/bi0027128 · doi-reference
A systematic study of the effect of physiological factors on β2-microglobulin amyloid formation at neutral pH
10.1021/bi052434i · doi-reference
Current clinical and pathogenetic understanding of β2-m amyloidosis in long-term haemodialysis patients
10.1046/j.1440-1797.8.s.10.x · doi-reference
Pathological aspects of beta-2-microglobulin amyloidosis
10.1046/j.1525-139x.2001.00037.x · doi-reference
Transthyretin sequesters amyloid β protein and prevents amyloid formation
10.1073/pnas.91.18.8368 · doi-reference